Bandingkan Harga & Kinerja Diagnos Laboratorium Utama Tbk. (DGNS) vs UBC Medical Indonesia Tbk. (LABS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Diagnos Laboratorium Utama Tbk. dan UBC Medical Indonesia Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp234 (kapitalisasi pasar 316,25 M, volume 24 jam 20,9 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp161 (kapitalisasi pasar 635,95 M, volume 24 jam 288,1 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 2× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (288,1 rb vs 20,9 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | LABS | |
|---|---|---|
Kapitalisasi Pasar | 316,25 M | 635,95 M |
Volume | 20,9 rb | 288,1 rb |
Lot | 209 | 2,88 rb |
Perputaran | 4,83 jt | 46,81 jt |
Harga Rata-rata | 231,06 | 162,49 |
Nilai Transaksi | 4,83 jt | 46,81 jt |
Harga Ekuilibrium Indikatif | 230 | 163 |
Volume Ekuilibrium Indikatif | 2,4 rb | 16 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →
